Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax Vaccines
Reports summarize anthrax vaccines research from Medical Research Institute
September 17th, 2008
New research, 'An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals,' is the subject of a report. According to recent research from the United States, "Samples of human plasma from anthrax vaccine adsorbed (AVA, BioThrax)-vaccinated individuals were used to demonstrate passive protection of A/J mice from a lethal challenge with the Sterne strain of anthrax bacteria. The maximum concentration of human anti-protective antigen IgG in mouse sera 24 h after injection of 260 microg of anti-PA IgG was 134 microg/ml, declining to 91 microg/ml at 72 h (half-life=101.7 h)." "Mice showed significant survival (p <or=0.001) after...
Source: Vaccine Weekly (2008-09-17)
|
